Global Bioenergies's small IPO: Size is not what matters

July 28, 2011 | Analyst Insight

Global Bioenergies recently went public on the NYSE Euronext, taking in €6.6 million (about $9 million) for a valuation of about $56 million. The company has developed a microorganism capable of excreting isobutene, an...